Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
HealthcareAdd-on
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Kailera Therapeutics Plans IPO for Obesity Drug
Announced
HealthcareOther
Deal Overview
Kailera Therapeutics plans an IPO focused on an obesity drug candidate intended to compete in the Zepbound category. The company’s public-market plans center on bringing its obesity-treatment program forward through a listing.
No pricing, proceeds, or terms are included in the provided material.
Key Details
- Target
- Kailera Therapeutics
Powered by Tentt
Source healthcare deals for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Related Deals
Seven-figure funding deal secures Swindon site acquisition for medical products firm
HealthcareAdd-on
Quvara Medical→Becton Dickinson
Apr 15, 2026
Indiana hospital signs LOI to join Parkview Health
HealthcareIndianaMerger
Parkview Health→Witham Health Services
Apr 15, 2026
What Surgery Partners’ vascular acquisition means for the industry
HealthcareTENNESSEEAdd-on
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra completes acquisition of AI firm Oxipit - AuntMinnie
HealthcareAdd-on
Sectra→Oxipit
Apr 15, 2026